Hexarelin is a synthetic six-amino-acid peptide and one of the more potent growth hormone secretagogues studied to date. It acts on the same receptor system as ghrelin to prompt the pituitary gland to release its own growth hormone in pulses, and it has additionally drawn research interest for direct effects on heart tissue. Hexarelin is a research-stage peptide. It is not approved by the FDA or by Thai regulators for the uses discussed here. At Menscape Clinic in Bangkok it would only ever be considered off-label, compounded by a licensed pharmacy partner and prescribed under physician supervision, and only where a doctor judges it appropriate. Much of the supporting evidence comes from small or short human studies and from animal work, so expectations are framed cautiously.
/)
Medically reviewed by Dr. Tuksaorn Suriyakan (Ping), Anti-Aging & Regenerative Medicine Physician
8 years of experience
Our solutions for Anti-Aging & Vitality
Indications evaluated in research, listed in order of current evidence weight. Suitability is determined case-by-case.
Hexarelin is a synthetic hexapeptide, meaning a chain of six amino acids, developed as a growth hormone secretagogue. A secretagogue does not supply growth hormone directly. Instead it signals the body to make and release more of its own. Hexarelin is regarded as one of the stronger peptides in this class. It binds the growth hormone secretagogue receptor (GHSR-1a), the same receptor activated by the natural hunger hormone ghrelin, and unusually it also interacts with a second receptor called CD36 that is present in heart and other tissue. This dual activity is part of why hexarelin has been studied beyond growth hormone alone. It remains a research-stage molecule with no regulatory approval for the uses described on this page, and the human evidence base is modest.
/)
By stimulating GHSR-1a in the pituitary and hypothalamus, hexarelin may trigger a pulse of the body's own growth hormone, which in turn can raise IGF-1, the downstream signal linked with tissue repair and metabolism. One practical limitation is well documented: with continuous, uninterrupted dosing the receptor can become desensitised, so the same dose produces a smaller response over time. For this reason it is studied in short or pulsed courses with breaks rather than indefinitely. The separate CD36 pathway is the focus of early cardiac research and is independent of growth hormone, but that work is largely preclinical and should not be read as evidence of a heart treatment.
/)
At Menscape Clinic in Bangkok, peptides in this category are discussed with men who are exploring the growth hormone and IGF-1 axis for recovery, body composition or general vitality, and who understand they are considering a research-stage, non-approved option. It is not appropriate for everyone. A doctor will review your history, goals and bloodwork first, and may recommend a more established or better-evidenced path instead. It is not used in anyone with active or suspected cancer, and it is unsuitable during pregnancy. Because hexarelin is prohibited in competitive sport by WADA, it is not appropriate for tested athletes.
/)
Where a physician judges it appropriate, hexarelin would be prescribed off-label and compounded by a licensed pharmacy partner, used under medical supervision rather than self-directed. A typical approach favours short, pulsed protocols to limit receptor desensitisation, with the lowest effective dose and planned breaks. The process at Menscape Clinic in Bangkok begins with a consultation and baseline testing, includes follow-up review, and treats the peptide as one part of a wider plan covering sleep, training, nutrition and overall men's health. Our English-speaking team can coordinate this for visiting and resident patients alike. No specific outcome is promised, and the plan is adjusted to how you respond.
/)
Every Hexarelin protocol starts with a full medical consultation and history review.
Prescriptions are filled by a licensed compounding pharmacy partner, not over-the-counter.
Follow-up consultations every four to six weeks to assess response and safety.
We frame Hexarelin as a research-stage option and prescribe only when clinically appropriate.
No. Hexarelin is not approved by the FDA, nor by Thai regulators, for the uses discussed here. It is a research-stage peptide. Where a doctor judges it appropriate, it would be prescribed off-label and compounded by a licensed pharmacy partner under medical supervision. It is also prohibited in competitive sport by WADA, so it is not suitable for tested athletes.
Hexarelin is considered one of the more potent growth hormone secretagogues, and it interacts with a second receptor (CD36) that most peptides in this class do not. The trade-off is that it can desensitise the receptor with continuous use, which is why it is studied in short, pulsed courses. A doctor can explain how it compares with gentler options for your goals.
It is researched mainly as a way to prompt the body's own growth hormone release, with interest in recovery, body composition and vitality through the GH and IGF-1 axis. It has also drawn early, largely preclinical attention for direct effects on heart tissue. Much of the data is from small or short human studies and from animal work.
Human safety data are limited, so it cannot be called proven safe. Reported considerations include effects on appetite, water retention, blood sugar and cortisol or prolactin, alongside the receptor desensitisation seen with continuous use. It is not used in anyone with active or suspected cancer and is unsuitable during pregnancy. Any use should be supervised by a physician with appropriate monitoring, and it is not recommended for self-administration.
With continuous, uninterrupted dosing the receptor can become desensitised, meaning the same dose may produce a smaller growth hormone response over time. This is a recognised reason it is studied in short or cycled protocols with planned breaks rather than open-ended daily use.
You would begin with a consultation and baseline testing so a doctor can assess whether a research-stage peptide is appropriate for you, or whether a more established option fits better. If it is prescribed, it would be off-label, compounded by a licensed pharmacy partner, supervised, and reviewed at follow-up. Our English-speaking team can coordinate this for visiting and local patients.
/)
Dr. Tuksaorn (Dr. Ping) is an anti-aging and regenerative medicine physician with over 8 years of experience, focused on evidence-based wellness and personalized health programs that combine modern medical science with individualized care.
/)
/)
/)
/)
/)